Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Short-chain fatty acids (SCFAs), such as butyrate, propionate, and acetate produced by the gut microbiota have been implicated in physiological responses (defense mechanisms, immune responses, and cell metabolism) in the human body. In several types of cancers, SCFAs, especially butyrate, suppress tumor growth and cancer cell metastasis via the regulation of the cell cycle, autophagy, cancer-related signaling pathways, and cancer cell metabolism. In addition, combination treatment with SCFAs and anticancer drugs exhibits synergistic effects, increasing anticancer treatment efficiency and attenuating anticancer drug resistance. Therefore, in this review, we point out the importance of SCFAs and the mechanisms underlying their effects in cancer treatment and suggest using SCFAproducing microbes and SCFAs to increase therapeutic efficacy in several types of cancers.
Abstract
Short-chain fatty acids (SCFAs), such as butyrate, propionate, and acetate produced by the gut microbiota have been implicated in physiological responses (defense mechanisms, immune responses, and cell metabolism) in the human body. In several types of cancers, SCFAs, especially butyrate, suppress tumor growth and cancer cell metastasis via the regulation of the cell cycle, autophagy, cancer-related signaling pathways, and cancer cell metabolism. In addition, combination treatment with SCFAs and anticancer drugs exhibits synergistic effects, increasing anticancer treatment efficiency and attenuating anticancer drug resistance. Therefore, in this review, we point out the importance of SCFAs and the mechanisms underlying their effects in cancer treatment and suggest using SCFAproducing microbes and SCFAs to increase therapeutic efficacy in several types of cancers.
참고문헌 (76)
- Kamal N, "Genesis and mechanism of some cancer types and an overview on the role of diet and nutrition in cancer prevention", Molecules, 27, pp.1794~ (2022)
- Negrei C, "Colon cancer cells gene expression signature as response to 5- fluorouracil, oxaliplatin, and folinic acid treatment", Front. Pharmacol, 7, pp.172~ (2016)
- Ma Y, "Targeting strategies for enhancing paclitaxel specificity in chemotherapy", Front. Cell Dev. Biol, 9, pp.626910~ (2021)
- Jaiyesimi IA, "Use of tamoxifen for breast cancer : twenty-eight years later", J. Clin. Oncol, 13, pp.513~529 (1995)
- Prince HM, "Anti-CD30 antibody-drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives", Ann. Hematol, 102, pp.13~29 (2023)
- Morganti S, "Role of immunotherapy in early- and late-stage triple-negative breast cancer", Hematol. Oncol. Clin. North Am, 37, pp.133~150 (2023)
- Abelman RO, "Current and emerging role of antibody-drug conjugates in HER2-negative breast cancer", Hematol. Oncol. Clin. North Am, 37, pp.151~167 (2023)
- Martin C, "Current and novel therapeutic strategies for optimizing immunotherapy outcomes in advanced non-small cell lung cancer", Front. Oncol, 12, pp.962947~ (2022)
- Fernandes MR, "Targeting the gut microbiota for cancer therapy", Nat. Rev. Cancer, 22, pp.703~722 (2022)
- Zhang W, "Gut microbiota-derived metabolites in colorectal cancer: the bad and the challenges", Front. Oncol, 11, pp.739648~ (2021)
- van der Hee B, "Microbial regulation of host physiology by short-chain fatty acids", Trends Microbiol, 29, pp.700~712 (2021)
- Correa-Oliveira R, "Regulation of immune cell function by short-chain fatty acids", Clin. Transl. Immunol, 5, pp.e73~ (2016)
- Machado MG, "Short-chain fatty acids as a potential treatment for infections: a closer look at the lungs", Infect. Immun, 89, pp.e0018821~ (2021)
- He J, "Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism", Int. J. Mol. Sci, 21, pp.6356~ (2020)
- Davie JR, "Inhibition of histone deacetylase activity by butyrate", J. Nutr, 133, pp.2485S~2493S (2003)
- JaeJin An, "Combination Therapy of Lactobacillus plantarum Supernatant and 5-Fluouracil Increases Chemosensitivity in Colorectal Cancer Cells", Journal of Microbiology and Biotechnology, 26(8), pp.1490~1503 (2016), 한국미생물·생명공학회[DOI]
- Shuwen H, "Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancer", Transl. Oncol, 27, pp.101598~ (2023)
- Mirzaei R, "Role of microbiota-derived shortchain fatty acids in cancer development and prevention", Biomed. Pharmacother, 139, pp.111619~ (2021)
- Ryu TY, "Human gut-microbiome-derived propionate coordinates proteasomal degradation via HECTD2 upregulation to target EHMT2 in colorectal cancer", ISME J, 16, pp.1205~1221 (2022)
- Botta C, "Lactiplantibacillus plantarum inhibits colon cancer cell proliferation as function of its butyrogenic capability", Biomed. Pharmacother, 149, pp.112755~ (2022)
- Chang SC, "A gut butyrate-producing bacterium Butyricicoccus pullicaecorum regulates short-chain fatty acid transporter and receptor to reduce the progression of 1,2-dimethylhydrazine-associated colorectal cancer", Oncol. Lett, 20, pp.327~ (2020)
- Chang CC, "Butyrate supplementation regulates expression of chromosome segregation 1-like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer", Int. J. Oncol, 60, pp.64~ (2022)
- Chen D, "Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota", Cancer Lett, 469, pp.456~467 (2020)
- Ali SR, "Functional high-throughput screen identifies microRNAs that promote butyrate-induced death in colorectal cancer cells", Mol. Ther. Nucleic Acids, 30, pp.30~47 (2022)
- Wang L, "Butyrate drives metabolic rewiring and epigenetic reprogramming in human colon cancer cells", Mol. Nutr. Food Res, 66, pp.e2200028~ (2022)
- Park M, "Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patient-derived organoids", Int. J. Oncol, 57, pp.1307~1318 (2020)
- Geng HW, "Butyrate suppresses glucose metabolism of colorectal cancer cells via GPR109a-AKT signaling pathway and enhances chemotherapy", Front. Mol. Biosci, 8, pp.634874~ (2021)
- Zeng H, "Butyrate inhibits deoxycholic-acid-resistant colonic cell proliferation via cell cycle arrest and apoptosis: A potential pathway linking dietary fiber to cancer prevention", Mol. Nutr. Food Res, 64, pp.e1901014~ (2020)
- Klepinina L, "Colon cancer cell differentiation by sodium butyrate modulates metabolic plasticity of Caco-2 cells via alteration of phosphotransfer network", PLoS One, 16, pp.e0245348~ (2021)
- Xing C, "Interaction between microbiota and immunity and its implication in colorectal cancer", Front. Immunol, 13, pp.963819~ (2022)
- Coutzac C, "Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer", Nat. Commun, 11, pp.2168~ (2020)
- Hogh RI, "Metabolism of short-chain fatty acid propionate induces surface expression of NKG2D ligands on cancer cells", FASEB J, 34, pp.15531~15546 (2020)
- Ma X, "Sodium butyrate modulates gut microbiota and immune response in colorectal cancer liver metastatic mice", Cell Biol. Toxicol, 36, pp.509~515 (2020)
- Burd EM, "Human papillomavirus and cervical cancer", Clin. Microbiol. Rev, 16, pp.1~17 (2003)
- Zeber-Lubecka N, "Increased diversity of a cervical microbiome associates with cervical cancer", Front. Oncol, 12, pp.1005537~ (2022)
- Chu H, "Synergistic effects of sodium butyrate and cisplatin against cervical carcinoma in vitro and in vivo", Front. Oncol, 12, pp.999667~ (2022)
- Decrion-Barthod AZ, "Sodium butyrate with UCN-01 has marked antitumour activity against cervical cancer cells", Anticancer Res, 30, pp.4049~4061 (2010)
- Matsuya-Ogawa M, "Oncoprotective effects of short-chain faftty acids on uterine cervical neoplasia", Nutr. Cancer, 71, pp.312~319 (2019)
- Pham CH, "Anticancer effects of propionic acid inducing cell death in cervical cancer cells", Molecules, 26, pp.4951~ (2021)
- Yang J, "Role of the gastric microbiome in gastric cancer: from carcinogenesis to treatment", Front. Microbiol, 12, pp.641322~ (2021)
- Gajewski A, "Helicobacter pylori antigens, acetylsalicylic acid, LDL and 7-ketocholesterol - their potential role in destabilizing the gastric epithelial cell barrier. An in vitro model of Kato III cells", Acta Biochim. Pol, 63, pp.145~152 (2016)
- Yonezawa H, "Destructive effects of butyrate on the cell envelope of Helicobacter pylori", J. Med. Microbiol, 61, pp.582~589 (2012)
- Huang Y, "Effects of sodium butyrate supplementation on inflammation, gut microbiota, and short-chain fatty acids in Helicobacter pylori-infected mice", Helicobacter, 26, pp.e12785~ (2021)
- Li Y, "Combining sodium butyrate with cisplatin increases the apoptosis of gastric cancer in vivo and in vitro via the mitochondrial apoptosis pathway", Front. Pharmacol, 12, pp.708093~ (2021)
- Zhou Y, "Short-chain fatty acid butyrate: a novel shield against chronic gastric ulcer", Exp. Ther. Med, 21, pp.329~ (2021)
- Kim YL, "Metabolic alterations of short-chain fatty acids and TCA cycle intermediates in human plasma from patients with gastric cancer", Life Sci, 309, pp.121010~ (2022)
- Sun G, "Profiling and Characterization of microRNAs responding to sodium butyrate treatment in gastric cancer cells", Comb. Chem. High Throughput. Screen, 25, pp.1875~1888 (2022)
- Carrasquilla M, "High-risk non-small cell lung cancer treated with active scanning proton beam radiation therapy and Immunotherapy", Adv. Radiat. Oncol, 8, pp.101125~ (2023)
- Gui Q, "The association between gut butyrate-producing bacteria and non-smallcell lung cancer", J. Clin. Lab. Anal, 34, pp.e23318~ (2020)
- Xiao X, "Profiling and characterization of microRNAs responding to sodium butyrate treatment in A549 cells", J. Cell Biochem, 119, pp.3563~3573 (2018)
- Jin X, "TXNIP mediates the differential responses of A549 cells to sodium butyrate and sodium 4-phenylbutyrate treatment", Cancer Med, 6, pp.424~438 (2017)
- Zhang XZ, "Prediction of the mechanism of sodium butyrate against radiationinduced lung injury in non-small cell lung cancer based on network pharmacology and molecular dynamic simulations and molecular dynamic simulations", Front. Oncol, 12, pp.809772~ (2022)
- Chen L, "Propionate and butyrate produced by gut microbiota after probiotic supplementation attenuate lung metastasis of melanoma cells in mice", Mol. Nutr. Food Res, 65, pp.e2100096~ (2021)
- Kim K, "Propionate of a microbiota metabolite induces cell apoptosis and cell cycle arrest in lung cancer", Mol. Med. Rep, 20, pp.1569~1574 (2019)
- Cristiano C, "Oral sodium butyrate supplementation ameliorates paclitaxel-induced behavioral and intestinal dysfunction", Biomed. Pharmacother, 153, pp.113528~ (2022)
- Chen M, "Sodium butyrate combined with docetaxel for the treatment of lung adenocarcinoma A549 cells by targeting gli1", Onco. Targets Ther, 13, pp.8861~8875 (2020)
- Shi B, "Effect of sodium butyrate on ABC transporters in lung cancer A549 and colorectal cancer HCT116 cells", Oncol. Lett, 20, pp.148~ (2020)
- Kim K, "EHMT2 is a metastasis regulator in breast cancer", Biochem. Biophys. Res. Commun, 496, pp.758~762 (2018)
- Kim SK, "The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer", Int. J. Oncol, 54, pp.65~76 (2019)
- 류태영, "SETDB1 regulates SMAD7 expression for breast cancer metastasis", BMB Reports, 52(2), pp.139~144 (2019), 생화학분자생물학회[DOI]
- Schoeller A, "Short chain fatty acids exhibit selective estrogen receptor downregulator (SERD) activity in breast cancer", Am. J. Cancer Res, 12, pp.3422~3436 (2022)
- Semaan J, "Comparative effect of sodium butyrate and sodium propionate on proliferation, cell cycle and apoptosis in human breast cancer cells MCF-7", Breast Cancer, 27, pp.696~705 (2020)
- Yuksel B, "Evaluation of the antioxidative and genotoxic effects of sodium butyrate on breast cancer cells", Saudi J. Biol. Sci, 29, pp.1394~1401 (2022)
- Li X, "Triple-negative breast cancer has worse overall survival and causespecific survival than non-triple-negative breast cancer", Breast Cancer Res. Treat, 161, pp.279~287 (2017)
- Bianchini G, "Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease", Nat. Rev. Clin. Oncol, 13, pp.674~690 (2016)
- Sharma M, "Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition", Exp. Cell. Res, 416, pp.113160~ (2022)
- Karimi Z, "Evaluation of thermosensitive chitosan hydrogel containing gefitinib loaded cellulose acetate butyrate nanoparticles in a subcutaneous breast cancer model", Int. J. Pharm, 624, pp.122036~ (2022)
- Richters A, "The global burden of urinary bladder cancer: an update", World J. Urol, 38, pp.1895~1904 (2020)
- Tran L, "Advances in bladder cancer biology and therapy", Nat. Rev. Cancer, 21, pp.104~121 (2021)
- Martin A, "Bladder cancer, inflammageing and microbiomes", Nat. Rev. Urol, 19, pp.495~509 (2022)
- Wang YC, "Supplementation of probiotic Butyricicoccus pullicaecorum mediates anticancer effect on bladder urothelial cells by regulating butyrate-responsive molecular signatures", Diagnostics (Basel), 11, pp.2270~ (2021)
- Wang F, "Sodium butyrate inhibits migration and induces AMPK-mTOR pathwaydependent autophagy and ROS-mediated apoptosis via the miR-139-5p", Bmi-1 axis in human bladder cancer cells, 2020, pp.34, 4266~4282
- Maruyama T, "Apoptosis of bladder cancer by sodium butyrate and cisplatin", J. Infect. Chemother, 18, pp.288~295 (2012)
- Yu Q, "Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the cmyc", hexokinase 2 pathway, 2022, pp.26, 3031~3045
- Panebianco C, "Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models", Biomed. Pharmacother, 151, pp.113163~ (2022)
- Wang R, "Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate", Nat. Commun, 13, pp.2522~ (2022)
